← Leaderboards
Ann Bolinger
University Of California San Francisco
$25,799
Attributed
$25,799
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$25,799 · 1
By mechanism
M01$25,799 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- Diane W. Wara$7,985,315
- Michael D Prados$7,364,703
- Melvin B. Heyman$7,841,306
- Ann Petru$791,951
Others in their field
Top investigators on “Acute Myelogenous Leukemia”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- Brad H. Pollock · University Of Florida$28,646,726
- Gregory H Reaman · National Childhood Cancer Foundation$17,689,961
- Richard Aplenc · University Of Pennsylvania$16,894,374
- Daniel G Tenen · Beth Israel Deaconess Medical Center$16,073,131
Research focus
Acute Myelogenous LeukemiaBone Marrow TransplantationBusulfanChild (0-11)Clinical ResearchCombination Cancer TherapyDosageHuman SubjectHuman Therapy EvaluationNeoplasm /Cancer ChemotherapyPediatric Pharmacology
Grant awards (5)
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS$0
M01 · FY2002 · RR
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS$0
M01 · FY2001 · RR
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS$25,799
M01 · FY2000 · RR
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS$0
M01 · FY2000 · RR
DOSE ADJUSTMENT OF BUSULFAN IN BMT FOR CHILDREN WITH AML OR INBORN ERRORS$0
M01 · FY2000 · RR